HOLOVAST Selected for MaRS and Innovate UK Made Smarter Innovation Cohort, Canada
Holovast is selected for the MaRS x Innovate UK Made Smarter Innovation programme in Canada, supporting North American pilot readiness and partner engagement.
London, UK - 15 October 2025: HOLOVAST Ltd has been selected for the MaRS Discovery District x Innovate UK Made Smarter Innovation programme in Canada, supporting the company's expansion into the North American manufacturing ecosystem.
Delivered through MaRS in Toronto, the programme supports UK innovation companies scaling into international markets through structured market access, industry engagement, and commercial acceleration.
For HOLOVAST, this selection creates a practical pathway to collaborate with manufacturers seeking improvements in execution consistency, onboarding speed, and in-process quality performance.
The company will use this phase to strengthen pilot relationships, align deployment priorities with regional manufacturing needs, and validate where AI-powered industrial guidance can deliver measurable operational value.
Johnson Oluwadele, Founder and CTO of HOLOVAST, said:
"Canada provides a strong environment to validate manufacturing pilots and build long-term partnerships with organisations focused on practical innovation outcomes."
A feature covering the selected cohort is available from MaRS: https://www.marsdd.com/our-story/these-7-companies-are-looking-to-optimize-manufacturing-in-north-america/
About MaRS and Innovate UK Made Smarter Innovation
The programme supports UK companies with advanced manufacturing solutions to enter and scale in strategic international markets through partner access and ecosystem support.
About HOLOVAST Ltd
Holovast develops a governed operational knowledge and execution platform for physical work. It turns approved source material into reviewed workflows, delivers them through browser, tablet, or AR, and uses configured step evidence to control progression and correction. Holovast governs what AI may instruct, what a person or agent may act on, what evidence is required, and whether physical work may proceed.
For updates and partnership enquiries: